Rimeporide in Duchenne presented at the 20th WMS Congress

EspeRare presented the “Development of Rimeporide, a sodium-hydrogen exchanger inhibitor, as a therapy for Patients with Duchenne Muscular Dystrophy”  at the 20th International Congress of the World Muscle Society in Brighton from 30th September to 4th October 2015.

Click on picture to view

For more information on the WMS Congress click here